1XUO
X-ray structure of LFA-1 I-domain bound to a 1,4-diazepane-2,5-dione inhibitor at 1.8A resolution
Summary for 1XUO
Entry DOI | 10.2210/pdb1xuo/pdb |
Related | 1CQP 1XDD 1XDG |
Descriptor | Integrin alpha-L, MAGNESIUM ION, (2R)-2-[3-ISOBUTYL-2,5-DIOXO-4-(QUINOLIN-3-YLMETHYL)-1,4-DIAZEPAN-1-YL]-N-METHYL-3-(2-NAPHTHYL)PROPANAMIDE, ... (4 entities in total) |
Functional Keywords | i-domain, integrin, immune system |
Biological source | Homo sapiens (human) |
Cellular location | Membrane; Single-pass type I membrane protein: P20701 |
Total number of polymer chains | 2 |
Total formula weight | 43436.40 |
Authors | Wattanasin, S.,Kallen, J.,Myers, S.,Guo, Q.,Sabio, M.,Ehrhardt, C.,Albert, R.,Hommel, U.,Weckbecker, G.,Welzenbach, K. (deposition date: 2004-10-26, release date: 2005-10-26, Last modification date: 2024-03-20) |
Primary citation | Wattanasin, S.,Kallen, J.,Myers, S.,Guo, Q.,Sabio, M.,Ehrhardt, C.,Albert, R.,Hommel, U.,Weckbecker, G.,Welzenbach, K.,Weitz-Schmidt, G. 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1 Bioorg.Med.Chem.Lett., 15:1217-1220, 2005 Cited by PubMed Abstract: 1,4-Diazepane-2,5-diones (2) are found to be a new class of potent LFA-1 inhibitors. The synthesis, structure, and biological evaluation of these 1,4-diazepine-2,5-diones and related derivatives are described. PubMed: 15686945DOI: 10.1016/j.bmcl.2004.11.072 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report